A New Frontier: Microdosing
& Low-Dosing Psychedelics for

Cluster Headaches and Neurological Disorders

Discover the emerging science of psychedelic medicine in our live webinar with Clusterbusters and leading experts. Learn how psilocybin may treat debilitating cluster headaches and other neurological conditions.

Wednesday, September 24th, 2025 (online)
12:00 PM PST | 3:00 PM EST | 8:00 PM GMT
60 minutes with live Q&A

Secure your spot

For people living with cluster headaches and other chronic neurological conditions, life can be defined by pain. Cluster headaches alone affect roughly 1 in 1,000 people globally and are often described as one of the most painful conditions known, earning the nickname “suicide headaches.” Despite widely available treatments, not all patients respond.

The use of low-dose psilocybin and other psychedelics is on the rise, with many people reporting benefits for specific conditions, including chronic headaches, as well as improvements in overall health and quality of life. Early reports are compelling, and researchers, doctors, and patient advocates are now working to build the data that could turn these experiences into science.

Join Microdosing Collective, Clusterbusters, and leading medical experts for a live webinar exploring the emerging role of psychedelics in treating some of the most debilitating neurological conditions.

What You’ll Learn:

Why cluster headaches and related conditions are so hard to treat, and what’s missing in standard care
How low-dose psychedelics may help regulate pain, inflammation, and neurological function
What the latest clinical observations and patient experiences are revealing
How the upcoming Microdosing Collective survey is helping collect data to support future research and access
Where science meets advocacy: the importance of patient voices in reshaping medical paradigms
Personal insights from someone living with cluster headaches, and the role microdosing has played in their care.